Pharma and BioTech Daily

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA recently approved a biosimilar of Stelara from Alvotech and Teva, set to launch early next year. Johnson & Johnson reported mixed sales performance for new multiple myeloma drugs, with Tecvayli sales exceeding expectations and Carvykti und

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentScientists have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug, which targets specific genetic mutations, has been successful in shrinking tumors in clinical t

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA new study published in the Journal of Oncology has revealed a groundbreaking discovery in cancer treatment. Researchers have found a novel combination of drugs that have shown significant efficacy in targeting and

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination therapy that has shown promising results in treating aggressive forms of cancer. The combination of targe

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private biotech funding is on the rise, with venture firms investing in cell therapy developments in cancer care. Century has acquired Clade Therapeutics and raised $60 million through a private placement led by Bain Capital to expand its cell therapy

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is planning to bring an RSV shot to adults aged 18-59, while Boehringer Ingelheim is facing staff layoffs due to biosimilar challenges. Amylyx made a rare move by pulling an ALS drug from the market. On the regulatory front, the FDA has approv

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer ResearchScientists have made a significant breakthrough in cancer research, discovering a new potential treatment that targets specific cancer cells without harming healthy cells. This discovery has the potential to revolut

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in the Journal of Oncology reported a groundbreaking new treatment for certain types of cancer. The treatment, which involves a combination of immunotherapy and targeted therapy, has shown p

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.In the latest edition of Gene Therapy Weekly, Verve pauses its base editing trial due to lab abnormalities in a study participant, prompting a shift in strategy. Ginkgo acquires another startup in search of more cell therapy tools, while Gritstone shar

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.This week's Commercialization Weekly highlights Bristol Myers' success with a Kras drug trial, Astrazeneca's FDA approval for a rare disease drug acquired from Alexion, FDA approval for Akebia's anemia pill after a previous reject